RxDoctor Payments DataLook up a doctor →

Andrea Wahner Hendrickson, MD

Medical Oncology · Rochester, MNNPI 1609883321

Payments from drug & device makers

$3,717,559in general payments, 2019–2025

Across 86 payments — averaging $43,227 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1.5M
  • GSK$1M
  • Tesaro, Inc.$934K
  • Astrazeneca UK Limited$152K
  • Pfizer$57K
  • Amgen$46K
  • plus $23K from 4 others

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie11$1,469,467
GSK29$1,035,952
Tesaro, Inc.30$933,996
Astrazeneca UK Limited3$151,587
Pfizer2$57,396
Amgen4$46,162
Merck2$17,384
AstraZeneca3$3,251
Clovis Oncology, Inc.1$1,725
Novartis1$640

How this compares

$3,717,559 in reported general payments places this provider in the 85th percentile of 133 medical oncology providers in Minnesota.

See all medical oncology providers in Minnesota

Medicare billing

Part B allowed, 2024
$1,598,611
Medicare patients
345
Services billed
58,253

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical oncology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →